Sequence polymorphisms in the receptor-binding domain of Plasmodium falciparum EBA-175: implications for malaria vaccine development.
Mamillapalli
Anitha
A
Malaria Research Centre, New Delhi, India.
Pattnaik
Priyabrata
P
Sharma
Monal
M
Sharma
Surya K
SK
Tyagi
Prajesh K
PK
Joshi
Hema
H
Chitnis
Chetan E
CE
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D000953:Antigens, Protozoan / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D019556:COS Cells; D002522:Chlorocebus aethiops; D003001:Cloning, Molecular; D004912:Erythrocytes / Q000502:physiology; D006801:Humans; D007194:India; D017780:Malaria Vaccines; D008969:Molecular Sequence Data; D010963:Plasmodium falciparum / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification; D011110:Polymorphism, Genetic; D011485:Protein Binding / Q000187:drug effects; D017434:Protein Structure, Tertiary / Q000235:genetics; D015800:Protozoan Proteins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D011817:Rabbits; D020539:Sequence Analysis, Protein; D014611:Vaccination
D000906:Antibodies; D000953:Antigens, Protozoan; D017780:Malaria Vaccines; D015800:Protozoan Proteins; C065668:erythrocyte-binding antigen 175, Plasmodium